Showing results (2031-2040 of 2,560) with videos related to

Sort By:
Pageof 256
The Prostate|May 6, 2015
A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancerDean A Troyer, Tamara Jamaspishvili, Wei Wei, et al.
Plos One|November 16, 2016
MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional StudyOkyaz Eminaga, Wei Wei, Sarah J Hawley, et al.
Cancer Research|July 27, 2021
RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate CancerMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
European Urology|January 12, 2020
Veterans Affairs Cooperative Studies Program Study #553: Chemotherapy After Prostatectomy for High-risk Prostate Carcinoma: A Phase III Randomized StudyDaniel W Lin, Mei-Chiung Shih, William Aronson, et al.
Prostate Cancer and Prostatic Diseases|July 20, 2016
A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable momentM A Liss, J M Schenk, A V Faino, et al.
Bladder Cancer (Amsterdam, Netherlands)|June 10, 2021
Plasmacytoid urothelial carcinoma: response to chemotherapy and oncologic outcomesLeonidas N Diamantopoulos, Ali Raza Khaki, Petros Grivas, et al.
The Journal of Urology|December 2, 2021
Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS CohortAdrian J Waisman Malaret, Peter Chang, Kehao Zhu, et al.
Science Advances|April 24, 2021
Three-dimensional microscale hanging drop arrays with geometric control for drug screening and live tissue imagingA Ganguli, A Mostafa, C Saavedra, et al.
Scientific Reports|October 30, 2021
Patient-derived organoids as a platform for modeling a patient's response to chemoradiotherapy in esophageal cancerTatiana A Karakasheva, Joel T Gabre, Uma M Sachdeva, et al.
Biochemistry|June 14, 2006
Crystal structures of DPP-IV (CD26) from rat kidney exhibit flexible accommodation of peptidase-selective inhibitorsKenton L Longenecker, Kent D Stewart, David J Madar, et al.
Pageof 256